We are live on ! Find out more
REGN icon

Regeneron Pharmaceuticals
REGN

371 hedge funds and large institutions have $17B invested in Regeneron Pharmaceuticals in 2013 Q2 according to their latest regulatory filings, with 371 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

14% more call options, than puts

Call options by funds: $300M | Put options by funds: $263M

Holders
371
Holders Change
+371
Holders Change %
–
% of All Funds
12.11%
Holding in Top 10
9
Holding in Top 10 Change
+9
Holding in Top 10 Change %
% of All Funds
0.29%
New
371
Increased
–
Reduced
–
Closed
–
Calls
$300M
Puts
$263M
Net Calls
+$37.1M
Net Calls Change
+$37.1M

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
BA
201
Boston Advisors
Massachusetts
$2.38M +$2.46M +10,580 New
SFP
202
Santa Fe Partners
New Mexico
$2.36M +$2.45M +10,501 New
MPA
203
Marvin & Palmer Associates
Delaware
$2.29M +$2.38M +10,200 New
GIP
204
Granite Investment Partners
California
$2.26M +$2.34M +10,044 New
BAM
205
Burnham Asset Management
New York
$2.25M +$2.33M +10,000 New
SCM
206
Sigma Capital Management
Connecticut
$2.25M +$2.33M +10,000 New
SMDAM
207
Sumitomo Mitsui DS Asset Management
Japan
$2.19M +$2.27M +9,730 New
MSU
208
Mizuho Securities USA
New York
$2.18M +$2.26M +9,712 New
OC
209
Oppenheimer & Co
New York
$2.18M +$2.26M +9,703 New
PI
210
Placemark Investments
Illinois
$2.15M +$2.22M +9,547 New
Nomura Holdings
211
Nomura Holdings
Japan
$2.13M +$2.18M +9,372 New
TAM
212
Tocqueville Asset Management
New York
$2.12M +$2.19M +9,425 New
PCA
213
Private Capital Advisors
Connecticut
$2.08M +$2.15M +9,250 New
NCA
214
NCM Capital Advisers
North Carolina
$2.05M +$2.12M +9,100 New
SB
215
Suntrust Banks
Georgia
$2.02M +$2.09M +8,986 New
UOC
216
UBS O'Connor
Illinois
$2M +$2.07M +8,900 New
AAM
217
Advisors Asset Management
Colorado
$2M +$2.07M +8,888 New
ST
218
Stifel Trust
Missouri
$1.98M +$2.05M +8,817 New
AAM
219
Aberdeen Asset Management
United Kingdom
$1.93M +$2M +8,600 New
QI
220
Qualcomm Inc
California
$1.93M +$2M +8,600 New
Janus Henderson Group
221
Janus Henderson Group
United Kingdom
$1.9M +$1.92M +8,248 New
NIP
222
Nicholas Investment Partners
California
$1.89M +$1.96M +8,416 New
MOACM
223
Mutual of America Capital Management
New York
$1.81M +$1.87M +8,051 New
NCGI
224
Next Century Growth Investors
Minnesota
$1.79M +$1.86M +7,979 New
SSI
225
Scott & Selber Inc
Texas
$1.79M +$1.86M +7,967 New
7 8
9
10 11

REGN Hedge Fund Activity: Q2 2013 in Review

371 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Regeneron Pharmaceuticals (REGN) for Q2 2013, worth a combined $17B.

Buyers outnumbered sellers: 371 funds opened new REGN positions and 0 closed out — a net gain of 371 holders — while 0 added to existing stakes and 0 trimmed.

  • 371 institutional investors held Regeneron Pharmaceuticals (REGN) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $17B of Regeneron Pharmaceuticals stock for Q2 2013.
  • 371 funds opened new Regeneron Pharmaceuticals positions in Q2 2013 and 0 closed out, a net change of +371 holders.

Based on aggregated 13F filings for Q2 2013.